Cargando…
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results
Autores principales: | Olshansky, Brian, Bhatt, Deepak L, Miller, Michael, Steg, Ph. Gabriel, Brinton, Eliot A, Jacobson, Terry A, Ketchum, Steven B, Doyle Jr, Ralph T, Juliano, Rebecca A, Jiao, Lixia, Granowitz, Craig, Tardif, Jean-Claude, Mehta, Cyrus, Mukherjee, Rajat, Ballantyne, Christie M, Chung, Mina K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141294/ https://www.ncbi.nlm.nih.gov/pubmed/33010162 http://dx.doi.org/10.1093/ehjcvp/pvaa118 |
Ejemplares similares
-
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
por: Bhatt, Deepak L., et al.
Publicado: (2020) -
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT
por: Olshansky, Brian, et al.
Publicado: (2023) -
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
por: Majithia, Arjun, et al.
Publicado: (2021) -
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT
por: Selvaraj, Senthil, et al.
Publicado: (2022) -
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses
por: Peterson, Benjamin E., et al.
Publicado: (2020)